TrkB is a member of the protein tyrosine kinase family (1, 2) and together with trkA and trkC it forms the trk subfamily of RTKs. TrkB is the receptor for the neurotrophins brain derived neurotrophic factor (BDNF) and neurotrophin 4/5, whereas other neurotrophin family members preferentially bind to other trk receptors, nerve growth factor to trkA and neurotrophin-3 to trkC (3) (4) (5) (6) .
The analysis of its cDNA has revealed that TrkB contains several protein domains common to other receptor tyrosine kinases (7) (8) (9) (10) . The extracellular domain of the receptor contains two cysteine rich regions separated by a leucine rich domain. Between those domains and the plasma membrane are two IG like regions that are followed by the transmembrane domain. Intracellular, the receptor contains the juxtamembrane domain that includes a Shc binding site, a tyrosine kinase domain and a tail region containing a PLC-gamma binding site.
Northern blot analysis of TrkB messages has indicated that a number of mRNAs are generated from the TrkB locus (7) which is located on human chromosome 9 (11) . Molecular cloning revealed the existence of several isoforms generated by alternative splicing. In the intracellular region, two isoforms are generated by this mechanism: a full length receptor containing the tyrosine kinase domain and a truncated form lacking it (TrkB-T1) (7, 9, 12) . In rodents, another truncated form (TrkB-T2) has been described, with an apparently identical splice site as that of TrkB-T1, but with a unique intracellular tail region (7) . The TrkB-T1 form can bind to neurotrophins and is internalized upon ligand binding (13) but due to the lack of a kinase domain cannot signal to the cytoplasm. Its exact function remains controversial. However, accumulating evidence suggest that the truncated TrkB isoforms act as dominant negative form (14, 15) , possibly suppressing neurotrophin action.
In addition to the alternative splicing of the intracellular regions, alternative splice forms lacking one or all of the leucine rich motifs in the extracellular region have been described (16) . The isoforms lacking the leucine rich motifs can no longer bind neurotrophins (16) . In chicken, additional splice variants were described, one in the extracellular juxtamembrane region with leads to a reduced affinity to NT 4/5 (17, 18) and others with unknown function in the cytoplasmic juxtamembrane region (18) . The splicing variant with reduced affinity to NT4/5 found in chicken was also found to be expressed in cultured human retinal pigmented epithelium cells (19) . Together, these data show that alternative splicing is used to generate molecules with different function from the TrkB locus. This is typical for higher eukaryotic gene regulation where about 60% of all genes are regulated by this mechanism (20 -22) . Since alternative splicing pathways can be regulated by extracellular signals (23), e.g. neuronal activity (24) the formation of splice variants is most likely important for neurotrophin signaling through TrkB.
As a first step to investigate the molecular mechanisms generating TrkB isoform diversity, we determined the gene structure of the human TrkB gene. We found that this gene is unusually large, contains a noncanonical intron and an extended repeat. The gene can produce 100 mRNA isoforms and 10 different proteins. However three forms, the full length receptor and two truncated receptors, one of which has a Shc binding site, are the major ones.
MATERIALS AND METHODS
Screening and sequencing. The human BAC library screen using ESTs matching the human TrkB cDNA sequence was kindly performed by the German Human Gene Center, Heidelberg. Additional library screens was performed using PCR products generated using primers TrkB-E18-F and TrkB-E19-R as a probe. Double stranded sequencing of the BAC clones was performed on an ABI Prism 370 sequencer using TrkB specific oligonucleotides. The sequencing protocol is from http://www.chori.org/bacpac/cyclesere.htm. Additional sequences were obtained by transposone insertion sequencing using the GPS-1 kit (NEB).
Cloning of the human full length and TrkB-T-Shc receptors.
The full length human receptor and human TrkB-T-Shc isoform were amplified from SH-SY5Y RNA using Pfx DNA polymerase and cloned in pEGFP-N1 by standard procedures.
RT-PCR. Splicing isoforms were detected by RT-PCR using the primers listed at http://www.stamms-lab.net/pub_data/TrkB_ splicing_primers.txt. Total RNA from human cortex was obtained from the National Brain Bank, Netherlands. Total RNA from SHSY-5Y cells was isolated using an RNeasy kit (Qiagen). Two micrograms RNA were used for first strand synthesis. One tenth of the RT reaction was later used as template for PCR. The PCR products were gel purified, cloned in a pCR 4 TOPO vector (Invitrogen) and sequenced.
Northern blot analysis. The primer pairs used for generating DNA probes can be found under http://www.stamms-lab.net/ pub_data/TrkB_splicing_primers.txt. Double stranded probes were labeled either by random priming (Megaprime, Amersham) or when the probes were shorter than 200 bp by PCR. For the PCR labeling, 10 to 100 pg DNA was amplified for 15 cycles in the presence of 10 pmol of each primer, 10 M dATP, dGTP, dTTP and 50 Ci ␥-P32-dCTP (3000 Ci/mmol). dNTPs were added to final concentration of 150 M and 5 additional cycles were performed. Single stranded DNA probes were generated by cycle extension using gel purified PCR products as a template. One nanogram of DNA was amplified for 35 cycles on presence of 10 pmol primer, 10 M dATP, dGTP, dTTP and 50 Ci ␥-P32-dCTP (3000 Ci/mmol). All probes were purified from the labeling mix using a dNTP removal kit (Qiagen). A human multiple tissue Northern blot (Clontech) was probed according to the manufacturer's instructions.
Computer analysis. Analysis was done using the GCG package (25) . Contig assembly was performed using the GCG or the Staden Package. Calculation of splice site scores was as described (26) . This calculation can be performed at http://www2.imcb.osaka-u.ac.jp/ splice/score.html.
The human genome was downloaded from the NCBI ftp site. We utilized scripts written in Perl to extract the introns from the genomic DNA. The intron locations were determined using the information in the mRNA field in the GeneBank file headers. The perl scripts are available for download from http://stamms-lab.net/ pub_data/.
Immunoprecipitation. Immunoprecipitations were performed as described (27) .
RESULTS

Isolation of the Human TrkB Gene
To isolate clones corresponding to the TrkB gene, we used three ESTs from the 5Ј, 3Ј and middle parts of the TrkB cDNA to probe a human genomic PAC library. 28 independent clones were obtained and verified by hybridization with TrkB specific oligonucleotides (Fig. 1) . Two of them were found to be false positives and one contained an internal recombination. Four clones (RPCIP704J22583, RPCIP704P04728, RPCIP704N1042 and RPCIP704F1647) covering the entire known mRNA sequence were obtained from the German resource center in Berlin and characterized further. The clones were sequenced by primer walking starting from the known exons. The list of primers can be obtained under http://www.stamms-lab.net/pub_data/trkB_sequencing_ primers.txt.
Structure of the Gene
Sequencing of the gene shows that it contains 24 exons and 23 introns ( Fig. 2A) . One remarkable feature of the gene is its large size. The gene spans at least 590 kbp. The exons are located in five clusters. The first cluster contains the putative promoter region and the exons 1-5. The start codon is present in exon 5. Approximately 30 kbp downstream of this exon is the second exon cluster comprised of exons 6 -15. These exons encode the extracellular part of the protein, the transmembrane region and part of the juxtamembrane domain. Exon 16 which is used in the truncated receptor (TrkB-T1) is located 50 kbp downstream. A large intron of at least 300 kbp separates this exon from the third cluster. The third cluster is composed of exons 17-19. Exons 17 and 18 encode the intracellular juxtamembrane part of the receptor. Exon 19 is an alternative terminating exon which is used in a new truncated receptor form (TrkB-T-Shc). The fourth cluster containing the exons coding for part of the kinase domain is located approximately 60 kbp downstream. It is separated by a 50 kbp intron from the last two exons that compose the carboxy terminal part of the kinase domain and the phospho lipase C gamma binding site. The exons vary in size from 36 to more than 6000 nt with median size around 100 nt. The introns range from 115 nt to more than 300 kbp. Another unusual feature of the TrkB gene is the presence of a ChAB4 repeat between exon 16 and 17. This 250 kbp large repeat is found about 50 times in the human genome (28) . The translational phase of the exons changes within the gene: three exons are in first, eight exons in second phase and seven in the third phase (Fig. 4) . The 
Structure of the 5Ј UTR
In order to analyze the 5Ј untranslated region of the gene, we amplified capped RNA using the generator method (Invitrogen). This technique uses subsequent dephosphorylation, decaping and RNA oligonucleotide ligation to amplify only capped pre-mRNA molecules, which results in the detection of putative transcription start sites (30 -32) . We employed this method on human RNA derived from SH-SY5Y cells. Sequencing of the clones revealed that the TrkB gene is transcribed from at least nine different start sites. Based on the number of clones, the transcriptional start at position 3014 (Fig. 2B) is the most common one. The putative promoter region shows no apparent initiator elements (i.e. TATA box) and is highly G/C rich. Computer prediction indicated the presence of two CpG islands in the promoter region (Fig. 2B) . We conclude that the TrkB promoter shows hallmarks of housekeeping genes and uses several transcriptional start sites.
The 5Ј UTR Contains Several Alternative Exons, One with Unusual Splice Sites
In addition to alternative transcription start site usage, diversity at the 5Ј UTR is generated by alternative splicing. Exon 2 can be alternatively spliced, using two different 3Ј splice sites. Furthermore, exons 3 and 4 do not contain 3Ј splice sites and therefore are not joined to exons 1 or 2. A remarkable feature of the 5Ј UTR is the presence of a noncanonical exon. Exon 4 uses a GC rather then a GT dinucleotide in the 5Ј splice site of its downstream intron. We searched the annotated genes in the human genome at NCBI for more introns containing such splice site. The search resulted in 832 examples which is 1% of all annotated introns. This introns can be found under ftp://stamms-lab.net/ pub/EID.
Alternative Splicing Patterns
We systematically searched the EST database with cDNA and genomic sequences form the TrkB locus and used RT-PCR and RACE to identify novel exons. We identified exons 1, 2, 3, 4, 17 and 19 that have not been previously described (Figs. 2B and 3A) . Two of them are cassette exons (exons 2 and 17), one has alternative 3Ј splice site (exons 2a and 2b), one exon is terminating with alternative polyadenylation site (exon 19) and three exons are generated from alternative transcription start sites (exons 1, 3 and 4) . When the nine different start sites are taken into account, the TrkB gene could generate 100 different mRNA isoforms which code for 10 different proteins. The protein domain composition is often reflected in the gene structure. In the human trkB gene, several protein domains Fig. 3B) . This shows that the overall protein structure is reflected in the gene structure.
Alternative exon usage is often a result of suboptimal splice sites. In order to assess the quality of the splice sites of the alternative exons, we calculated their score. The score expresses how well the splice site follows the consensus sequence and binds to the components of the spliceosome (Fig. 4) . With the exception of exon 4a, no strong deviations from the consensus were found in alternative exons. Exon 4a is described by a weak score, because it uses a noncanonical GC rather than a GT. The good match of the alternative splice sites with the mammalian consensus sequence indicates that their regulation might involve repressing, rather than activating splicing regulatory factors.
Expression of the Splicing Variants
To address the question how abundantly the individual splice variants are expressed, we amplified regions of the pre-mRNA containing alternative exons. As RNA template, we used RNA derived from human cortex and from the SH-SY5Y human neuroblastoma cell line (33) . As shown in Fig. 5 , the newly identified exon 17 is used in both human cortex and SH-SY5Y cells. In contrast, all other cassette exons represent minor forms. We conclude that part of the TrkB juxtamembrane region that is encoded by exon 17 is regulated by alternative splicing.
Isoform Diversity Is Generated by Usage of Different Polyadenylation Sites
Next, we asked how strong the exons with alternative polyadenylation sites are used. We investigated the presence of exon 24, 16 and 19 containing messages using Northern blot analysis of human RNA. We found that the TrkB gene generated three major isoforms, the full length tyrosine receptor kinase (TrkB), a form lacking the catalytic domain (TrkB-T1) and a form lacking the catalytic domain but possessing a Shc site (TrkB-T-Shc). The full length TrkB form uses the stop codon and polyadenylation site present in exon 24 and is predominantly expressed in brain (Fig. 6A) . The previously described TrkB-T1 form is expressed in multiple tissues. However, expression is highest in brain, pancreas, kidney and heart (Fig. 6B) .
TrkB-T-Shc, a Novel TrkB Isoform Predominantly Expressed in Brain
When we searched the EST database with each individual exon sequence, we detected an EST (accession number AL134306.1) containing a novel alternative spliced exon (exon 19). We obtained the EST clone from the German Resource center in Berlin and subsequent sequencing showed that it contains part of exon 18 and a large single exon (exon 19) ending with a poly A tail (accession number AF410898). Since exon 19 contains a stop codon and a polyadenylation site, its usage leads to a truncated protein (accession number AF410901 and accession number AF410900), similar to the TrkB-T1 isoform. However, in contrast to the TrkB-T1 isoform, this isoform results in a protein that retains the Shc binding site (Fig. 6C) . Northern blot analysis reveals that this new isoform is predominantly expressed in the brain (Fig. 6C) . Therefore, there are two different classes of tyrosine kinase deficient TrkB receptors in human brain. The TrkB-T1 form which is also found in other tissues can not signal to Shc and the TrkB-T-Shc which is brain specific and could bind to Shc.
FIG. 6.
Protein structure and RNA expression pattern of the major TrkB variants. The structure of the coding mRNA part is indicated on the left and the corresponding domain structure of the resulting protein is indicated below the RNA. The expression pattern of the mRNA in humans was determined by Northern blot analysis and is shown on the right for each major TrkB variant. The cDNA probe used to detect the expression pattern is shown as a gray bar above the RNA structure.
TrkB-T-Shc Is Present in Mouse
To determine whether the newly found exons 17 and 19 are present in rodents we screened the ENSEMBL trace repository (34) . Several traces were detected with exon 19 sequence and were assembled using the Staden Package (http://www.mrc-lmb.cam.ac.uk/pubseq/). The alignment with the human TrkB sequence shows high similarity, which is not only confined to the coding sequence but extends into the 3Ј UTR and the upstream intron (Fig. 7A) . RT-PCR analysis showed brain specific expression of exon 19 (Fig. 7B) . Interestingly it is not detectable in primary astrocytes but is present in cultured neurons from embryonic cortex (Fig. 7B) , mesencephalon and superior cervical ganglia (data not shown). The RT-PCR and the trace repository screens do not show any evidence for a mouse exon that will correspond to the human exon 17.
TrkB-T-Shc Is Not Phosphorylated by Full Length TrkB
We wondered whether the novel TrkB-T-Shc isoform could be part of the established TrkB signaling pathway. As a first step we determined whether it interacts with the full length TrkB isoform. We therefore cotransfected Flag-tagged full length TrkB with EGFP tagged TrkB-T-Shc. Immunoprecipitation with antiFlag-antibody followed by Western blot analysis with anti-EGFP antibody revealed that both forms coimmunoprecipitate (Fig. 8A) . As the Shc site of the full length receptor is phosphorylated upon its activation we were interested if the Shc site of TrkB-T-Shc can be phosphorylated by the catalytic variant. We therefore cotransfected human full length TrkB receptor cDNA with TrkB-T-Shc expression constructs. The expressed protein was immunoprecipitated with anti-EGFP antibody and the immunoprecipitates were analyzed for tyrosine phosphorylation. Whereas the full length receptor was tyrosine phosphorylated, no phosphorylation of the TrkB-T-Shc variant is detectable (Fig. 8B) .
TrkB-T-Shc Localizes to the Plasma Membrane
Since TrkB-T-Shc differs in its phosphorylation properties form TrkB, we next wished to determine its intracellular distribution. As shown in Fig. 9 , EGFP tagged TrkB-T-Shc localizes predominantly to the membrane and is also present inside the cell. We conclude that TrkB-T-Shc is present in the same cellular compartment as the full length receptor and could therefore interfere with its function.
DISCUSSION
General Structure of the TrkB Gene
Here we describe the characterization of the human TrkB gene. We sequenced approximately 300 kbp of the gene and the latest assembly of the human genome estimates the gene size to be about 350 kbp. However, this sequence contains two clone gaps. Our results show the presence of a ChAB4 repeat at the gap location (Fig. 2) . ChAB4 repeats are characteristic for humans and chimpanzee. Only a few copies of these repeats are found in gorilla and orangutan. ChAB4 repeats have been estimated to be about 240 kbp in size. This suggest a gene size of at least 590 kbp. One large intron, located between exons 16 and 17 accounts for at least half its size. This is well above the average for the human genes that have a median of 14 kbp and a mean of 27 kbp in their size distribution. The presence of the ChAB4 repeat is another unusual feature, as there are only about 50 such repeats present on ten different human chromosomes (35) . The TrkB gene consists of 24 exons which can be grouped into six clusters. Our analysis of the 5Ј UTR showed that the gene uses at least nine different start sites. The promoter is located in a CpG island. No apparent initiator elements could be detected. The combination of alternative exon and promoter usage generates TrkB mRNAs with considerable variation in their 5Ј UTRs. The alternative promoters do not create protein isoforms. The exact function of this divergence remains to be determined, but alterations in the 5Ј UTRs are generally associated with differences in translation efficiency (36) . The overall gene structure of the human TrkB gene is similar to the gene structure of TrkC (37) . Furthermore, similar to the mouse TrkB gene (38) and the human TrkC gene (37) it uses TATA-less promoters located in CpG islands.
Alternative Splicing Variants
A combination of alternative splicing, alternative polyadenylation and alternative promoter usage leads to 100 isoforms that can encode 10 different proteins. Our RT-PCR analysis reveals that most of these alternative exons are not abundantly used, suggesting that they might fulfill specialized roles only in small cell populations or during certain developmental stages. Transcription and splicing occur simultaneously in a large complex, termed transcriptosome or "RNA factory" (39 -41) . Most alternative spliced exons of the TrkB gene are flanked by splice sites following the human consensus, indicating that their alternative use is due to repression mechanisms that remain to be elucidated. The only exon with suboptimal splice sites is exon 4 that uses a GC instead of the canonical GT at its 5Ј splice site. A recent survey found 162 GC-AG introns derived from 145 genes (42) . Our own survey found 832 GC-AG introns in the human genome which corresponds to about 1% of all annotated introns. The exact splicing mechanism of those introns remains to be determined. It could involve either optimized base pairing at the GC 5Ј splice site to U1 snRNA, or different mechanism, such as changing GC to GU by an editing event. The large size of the TrkB introns makes it likely that introns will be removed stepwise, as found for the ultrabithorax genes (43) . It could also be used to regulate the alternative splicing pattern of the gene, as three of the largest introns (15, 16 and 19) separate the alternative exons that generate the three major isoforms. 
Novel Isoform
Similarly to TrkC (44 -46) , the TrkB gene generates two types of noncatalytic isoforms, which are conserved in human and rodents. The usage of exon 19 results in a new truncated TrkB isoform TrkB-T-Shc. In contrast to the previously described truncated isoforms TrkB-T1 and TrkB-T2 this variant has a Shc binding site. Another difference is its expression pattern. The formerly described TrkB-T1 variant is expressed in most tissues, but the novel TrkB-T-Shc isoform is expressed only in brain and is neuron specific. Sequence analysis shows that this isoform is highly conserved between humans and mouse. This indicates that it could play an important role in TrkB signal transduction. We therefore determined its ability to be phosphorylated by the full length TrkB receptor. To our surprise, the full length receptor could bind to the TrkB-T-Shc isoform, but was unable to phosphorylate it. Overexpressed TrkB-T-Shc is present in the plasma membrane and similar to the full length TrkB receptor accumulates inside the cell. Since the TrkB-T-Shc isoform is present only in neurons, it might regulate the function of the catalytic form of the TrkB receptor. It could act as a dominant negative form in regards to the full length receptor the same way the TrkB-T1 isoform does. Alternatively it could have a specific function in (47) . Furthermore, the existence of a brain specific truncated isoform raises the question about the function of the TrkB-T1 isoform that is present in most tissues.
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